| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6667050 | APIL | Chewable oral contraceptive |
Apr, 2019
(5 years ago) | |
Femcon Fe is owned by Apil.
Femcon Fe contains Ethinyl Estradiol; Norethindrone.
Femcon Fe has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Femcon Fe are:
- US6667050
Femcon Fe was authorised for market use on 14 November, 2003.
Femcon Fe is available in tablet;oral dosage forms.
Femcon Fe can be used as prevention of pregnancy.
The generics of Femcon Fe are possible to be released after 06 April, 2019.
Drugs and Companies using ETHINYL ESTRADIOL; NORETHINDRONE ingredient
Market Authorisation Date: 14 November, 2003
Treatment: Prevention of pregnancy
Dosage: TABLET;ORAL
More Information on Dosage
FEMCON FE family patents
